Gilead Sciences, Inc. (GILD) - Stock Prices, Stock Peers & Analysis

Home
GILD

Company Name	Gilead Sciences, Inc.
Symbol	GILD
Currency	USD
Price	111.75
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	139,009,177,500
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	4.46%
52-week-range	66.01 - 119.96
Industry	Drug Manufacturers—General
Sector	Healthcare
CEO	Mr. Daniel P. O'Day
Website	https://www.gilead.com

An error occurred while fetching data.

About Gilead Sciences, Inc.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use,